SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CEMPRA INC
(NQNM:CEMP Last Sale: 8.89 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CEMP : $8.89)
$176 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 10/29/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Developing antibiotics for treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic and acute staphylococcal infections. Lead program is CEM-101, developing in both oral and intravenous, or IV, formulations initially for the treatment of community-acquired bacterial pneumonia, or CABP, which is one of the most serious infections of the respiratory tract. IPO at $6 February 2, 2012. Raised $50.4 million, selling 8.4 million shares, 42% of the outstanding. Lead Manager: Stifel Nicolaus.
Historical Charts    Technical Analysis
No Historical Data available for CEMP

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CEMP $8.89 $ 0 $8.8 $9.24 47,375 $5.26 $9.54 19,769
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $175,746

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex